Psilocybin therapeutic use program establishment

Summary

The bill establishes a state‑run psilocybin therapeutic use program that registers patients, facilitators, and suppliers. It sets eligibility (age 21+, qualifying medical condition, physician certification) and defines the roles of facilitators, administration, preparation, and integration sessions. The program is overseen by the health commissioner and an advisory committee, with rules, fees, and penalties authorized.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Topics

Share